An Update from the International Guillain-Barre Study (IGOS) by Dr. Bart Jacobs
The IGOS-1000 cohort has now been tested for the main preceding infections and is currently tested for antibodies extensively. We have also recently finalized a study in IGOS on the association between GBS and SARS-CoV-2 during the first 3 months of the pandemic. In my view this study shows the importance of having an ongoing…
GBS|CIDP Foundation Announces New Chairman of GMAB
On June 1, 2020, Dr. Ken Gorson officially passed the leadership to Dr. Peter Donofrio as Chairman of our esteemed Global Medical Advisory Board (GMAB). We thank Dr. Gorson for his leadership and many contributions in the past three years including the leadership of the US International Guillain-Barre Syndrome Outcome (IGOS) program, the Zika Virus…
Update from the International Guillain–Barré Syndrome Outcome Study (IGOS)
Diagnosis and management of Guillain–Barré syndrome in ten steps Portuguese Spanish Chinese Nature Reviews Neurology: https://www.nature.com/articles/s41582-019-0250-9; Published Sept 20, 2019. Explanation of the above referenced article below.https://creativecommons.org/licenses/by/4.0/ Authors: Sonja Leonhard, Melissa Mandarakas, Francisco de Assis Aquino Gondim, Kathleen Bateman, Maria Lúcia Ferreira, David Cornblath, Pieter van Doorn, Mario Dourado, Richard Hughes, Badrul Islam, S Kusunoki, Carlos Pardo, Ricardo Reisin, Jim…
Dr. Bart Jacobs, Vice Chairman of GMAB, and co-authors, “Editor’s Choice,” Brain Journal
An article published in Brain Journal, September 25, 2018, regarding research findings of the International Guillain Barre Outcome Survey (IGOS), partially supported by GBS|CIDP Foundation International, received the “Editor’s Choice.” Findings of IGOS are significant to the GBS community as noted in the abstract summary of article
2018 Research Grant Finalists Announced
We are pleased to announce our 2018 Research Grant Awardees.
GBS|CIDP Foundation International’s Global Medical Advisory Board recommendations on Zika virus and Guillain-Barré syndrome
PHILADELPHIA, /PRNewswire/ — The GBS|CIDP Foundation International has been closely following the fast moving story of Guillain-Barré syndrome following Zika infection first in French Polynesia and now in South America. On February 29, 2016, The Lancet released the first full account of the French Polynesian experience with GBS and Zika. The worldwide incidence of GBS…
Incidence of Guillain-Barré Syndrome Rising As Zika Spreads
Dr. Kenneth C. Gorson, MDPresident Elect GBS|CIDP Foundation International Global Medical Advisory BoardGuillain-Barre syndrome (GBS)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Medical Research: What is Guillain-Barré Syndrome? What are the main symptoms?Dr. Gorson: Guillain-Barré Syndrome (GBS) is an immune mediated disorder affecting the peripheral motor and sensory nerves and nerve roots, and is the most common cause…